Survey of the Use of Biotechnology in U.S. Industry

The report from the Office of Technology Policy provides a comprehensive and detailed look at the emerging U.S. biotech industry. The survey found respondents who are engaged in biotechnology research, development and applications reported in 2001 they had more than 1.1 million employees, total annual net sales of about $567 billion, operating income of $100.5 billion, capital expenditures of $29.5 billion, and R&D expenditures of $41.6 billion.